This site serves as a resource for Penn State College of Medicine faculty, staff, students and postdocs as the college prepares to ramp back up its on-campus efforts. This site will serve as the most up-to-date, reliable information about coronavirus disease 2019, also known as COVID-19.
Current status: COM Phase 4
- All on-site personnel must follow safety guidance including universal masking.
- No more than 80% of a department or institute may be on site at any one time, with physical distancing requirements in place that also limit the number of people in any lab, conference room or classroom.
- Observational human-subjects research may take place in certain circumstances, with appropriate limits to capacity in spaces such as the Clinical Research Center.
- Anyone whose work can be completed remotely should still be working off-site.
- All seminars, group meetings and one-on-one meetings should be conducted remotely if at all possible.
- Animals may be ordered without preapproval from Comparative Medicine, but those with large orders should still contact the animal facilities to ensure that animals can be accommodated in the vivarium.
- All learners should contact their program leadership with questions. That can be done via this form: Submit a COVID-19 question
- Student Health: 717-531-5998
- Employee Health: 717-531-4208
- Biosafety: 717-531-5573, 717-531-0003, ext. 289844 or BiosafetyOfficer@
- COM HR: askCOMHR@
All requests for media interviews should be made through the Office of Marketing and Communications.
Any Penn State Health/Penn State College of Medicine employee who is contacted by a member of the media should direct the media contact to reach Marketing and Communications by calling the following numbers:
College of Medicine COVID-19 response
From clinical trials of new potential treatments, to student projects supporting campus faculty and staff, to finding new ways to produce personal protective equipment, Penn State College of Medicine is committed to making a difference in the fight against COVID-19.